| NCT ID | NCT07153432 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute for Clinical and Experimental Medicine |
| Condition | Chronic Kidney Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2025-02-24 |
| Primary Completion | 2025-10-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2025-02-24 with a primary completion date of 2025-10-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to assess epidemiology of chronic kidney disease in patients followed at a tertiary care center. The main question it aims to answer is: What is the proportion of patients with chronic kidney disease overall and how many are previously undiagnosed.
Eligibility Criteria
Inclusion Criteria: * age \> 50 or age \>18 + one of these conditions (history of diabetes, arterial hypertension, ischemic heart disease, stroke, perpheral artery disease, atrial fibrillation, heart failure) * agree to participate * followed at the Institute for Clinical and Experimental Medicine Exclusion Criteria: * unwilling to participate * kidney transplant recipient/previous kidney transplantation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07153432 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07153432 currently recruiting?
Yes, NCT07153432 is actively recruiting participants. Contact the research team at zahi@ikem.cz for enrollment information.
Where is the NCT07153432 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT07153432 clinical trial?
NCT07153432 is sponsored by Institute for Clinical and Experimental Medicine. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.